After two relapses, CAR T-cell therapy and a stem cell transplant, William Yank is in remission. But infertility, mental ...

Because most women with HR-positive breast cancer are advised to avoid hormone therapy, a nonhormonal option matters. The FDA ...

A breast surgeon explains how rebuilding the breast with a person's own tissue and new tools may boost satisfaction and cut ...

Primary care and non-oncology clinicians frequently face nuanced cancer-therapy questions, making decision support valuable where relationships and longitudinal context often reside outside oncology.

Interim analysis crossed futility, indicating proton therapy was unlikely to demonstrate an overall survival benefit versus photons if accrual and follow-up continued. Median overall survival favored ...

Survivorship introduces financial toxicity beyond direct medical costs, exemplified by barriers to obtaining affordable life insurance in young adults with recurrence risk. Long-term care planning ...

Dr. Koehne explained that some people will still receive chemotherapy as initial, or induction, treatment. After that, ...

A mastectomy, or a mastectomy with reconstruction, is a much bigger surgery. Those patients typically spend one night in the ...

CONVERGE is studying patients with locally advanced non-small cell lung cancer who are receiving chemoradiation followed by ...

Jyoti Malhotra, MD, MPH on first-in-human clinical trials, lung cancer precision medicine in 2026, the disparities tension in drug development, and her move to Yale Cancer Center. In this episode ...

Survivors and experts who have spoken with CURE share what to do before your first infusion, from saving your hair and protecting your skin to building a support team. The good news is that patients ...